SanBio (4592) · RiskRestated
Risk of Adverse Effects and Product Liability
First written in FY2017. 3 of 4 entries say "Restated". Latest entry: FY2023.
4entries
7years
0from disclosures
How it moved
Same theme, other companies
Health Damage and Product Liability Risks Associated with PharmaceuticalsA theme 58 companies write about · 67 as a headwind · 1 as a tailwind
The whole theme swung hardest in 2026: 6 of 20 companies on the "Worse" side.
36 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 58 companies compared. The sentences above are computed from all 58.Full recordFilings, disclosures and news, newest first
- FY2023RestatedAnnual report
「Medicinal products may cause unforeseen adverse effects from the clinical-trial stage and, further, after launch.」
The risks of unforeseen adverse effects from the clinical-trial stage through the post-launch period, product liability and loss of confidence have been reaffirmed. - FY2020RestatedAnnual report
「Medicinal products may cause unforeseen adverse effects from the clinical-trial stage and, further, after launch.」
The risks of unforeseen adverse effects from the clinical-trial stage through the post-launch period, product liability and loss of confidence have been reaffirmed. - FY2019RestatedAnnual report
「Medicinal products may cause unforeseen adverse effects from the clinical-trial stage and, further, after launch.」
The risks of unforeseen adverse effects from the clinical-trial stage through the post-launch period, product liability and loss of confidence have been reaffirmed. - FY2017First statedAnnual report
「Medicines may produce unexpected adverse effects from the clinical-trial stage through and after commercial launch.」
The risks identified include unforeseen adverse effects from the clinical-trial stage through the post-launch period, liability for damages and loss of confidence.